Our recent findings also demonstrated that mice with global genetic deletion of RIPK2 or conditional deletion of microglial RIPK2 showed reduced effects on infarct volume and improved neurobehavioral outcomes after ischemic stroke compared to their WT littermates [12]. The gene discussed is RIPK2; the disease is ischemic stroke.